Key facts

Active Substance
3,6-diamino-2,5-bis{N-[(1R)-1-carboxy-2-hydroxyethyl]carbamoyl}pyrazine (MB-102)
Therapeutic area
  • Diagnostic
  • Uro-nephrology
Decision number
P/0457/2022
PIP number
EMEA-001983-PIP01-16-M01
Pharmaceutical form(s)
Solution for injection
Condition(s) / indication(s)
Monitoring of renal function
Route(s) of administration
Intravenous use
Contact for public enquiries

MediBeacon Inc.

United States
Tel.: +1 3147350971
E-mail: hanley@medibeacon.com

Decision type
PM: decision on the application for modification of an agreed PIP
Decision date

Decision

Share this page